Actively Recruiting
ATTR Cardiac Amyloidosis in a Selected Population
Led by Helse Møre og Romsdal HF · Updated on 2024-10-16
180
Participants Needed
1
Research Sites
756 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Patients operated for carpal tunnel syndrome (CTS) at Ålesund Hospital (200 patients) will have a biopsy to diagnose ATTR amyloidosis. Patients with positive biopsy will be examined to decide wether they have cardiac amyloidosis. All patients with positive biopsy will be followed closely for 10 years wit echocardiography an clinically.
CONDITIONS
Official Title
ATTR Cardiac Amyloidosis in a Selected Population
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male over 50 years old
- Female over 60 years old
- Have had surgery for carpal tunnel syndrome at Ålesund Hospital
You will not qualify if you...
- Have not given consent
- Do not speak Norwegian
- Have secondary cause of carpal tunnel syndrome such as trauma or rheumatic disease
- Cannot be followed for more than 5 years due to other medical conditions
- Have cardiac disease at the time of carpal tunnel syndrome operation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ålesund Hospital
Ålesund, Møre og Romsdal, Norway, 6026
Actively Recruiting
Research Team
T
Torstein Hole, Professor, MD, PhD
CONTACT
J
Jørn A Lillebø, consultant cardiology, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here